| Primary |
| Asthma |
18.2% |
| Pharyngitis |
13.6% |
| Cough |
9.1% |
| Oropharyngeal Discomfort |
9.1% |
| Acute Sinusitis |
4.5% |
| Allergic Sinusitis |
4.5% |
| Bronchitis |
4.5% |
| Cardiac Failure |
4.5% |
| Cardiac Failure Chronic |
4.5% |
| Epiglottic Cyst |
4.5% |
| Nasopharyngitis |
4.5% |
| Pneumonia |
4.5% |
| Product Used For Unknown Indication |
4.5% |
| Pyrexia |
4.5% |
| Rhinitis Allergic |
4.5% |
|
| Cardiomyopathy |
11.1% |
| Drug Eruption |
11.1% |
| Drug-induced Liver Injury |
11.1% |
| Eosinophilic Pneumonia |
11.1% |
| Liver Disorder |
11.1% |
| Neuropathy Peripheral |
11.1% |
| Productive Cough |
11.1% |
| Rash |
11.1% |
| Tonic Convulsion |
11.1% |
|
| Secondary |
| Asthma |
23.7% |
| Respiratory Disorder |
16.2% |
| Product Used For Unknown Indication |
11.0% |
| Drug Use For Unknown Indication |
9.8% |
| Cardiac Failure |
6.9% |
| Nasopharyngitis |
5.8% |
| Dermatitis Atopic |
4.6% |
| Oropharyngeal Discomfort |
3.5% |
| Osteoarthritis |
2.3% |
| Pharyngitis |
2.3% |
| Allergic Sinusitis |
1.7% |
| Cough |
1.7% |
| Epiglottic Cyst |
1.7% |
| Pneumonia |
1.7% |
| Benign Prostatic Hyperplasia |
1.2% |
| Bronchitis |
1.2% |
| Cardiac Failure Chronic |
1.2% |
| Hypertension |
1.2% |
| Hypertonic Bladder |
1.2% |
| Pyrexia |
1.2% |
|
| Cardiac Failure |
12.1% |
| Hepatic Function Abnormal |
12.1% |
| Drug-induced Liver Injury |
9.1% |
| Malaise |
9.1% |
| Pyuria |
6.1% |
| Urticaria |
6.1% |
| Vomiting |
6.1% |
| Brain Natriuretic Peptide Increased |
3.0% |
| Convulsion |
3.0% |
| Death |
3.0% |
| Drug Hypersensitivity |
3.0% |
| Enuresis |
3.0% |
| Epstein-barr Virus Antibody Positive |
3.0% |
| Hallucination |
3.0% |
| Liver Disorder |
3.0% |
| Pleural Effusion |
3.0% |
| Polyuria |
3.0% |
| Rash |
3.0% |
| Shock |
3.0% |
| Tonic Convulsion |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.5% |
| Asthma |
33.4% |
| Hypertension |
3.5% |
| Bronchitis |
3.0% |
| Drug Use For Unknown Indication |
2.7% |
| Respiratory Disorder |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| Nasopharyngitis |
1.9% |
| Prophylaxis |
1.7% |
| Rhinitis Allergic |
1.7% |
| Depression |
1.6% |
| Macular Degeneration |
1.5% |
| Emphysema |
1.5% |
| Pneumonia |
1.5% |
| Upper Respiratory Tract Inflammation |
1.5% |
| Cardiac Failure Chronic |
1.4% |
| Angina Pectoris |
1.3% |
| Otitis Media |
1.3% |
| Constipation |
1.2% |
| Gastritis |
1.2% |
|
| Asthma |
21.8% |
| Hepatic Function Abnormal |
7.9% |
| Tremor |
6.9% |
| Pyrexia |
5.9% |
| Wheezing |
5.9% |
| White Blood Cell Count Increased |
5.0% |
| Dyspnoea |
4.0% |
| Erythema Multiforme |
4.0% |
| Status Asthmaticus |
4.0% |
| Vasculitis |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Abnormal Behaviour |
3.0% |
| Cardiac Failure |
3.0% |
| Gastritis Atrophic |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Liver Disorder |
3.0% |
| Loss Of Consciousness |
3.0% |
| Parosmia |
3.0% |
| Platelet Count Decreased |
3.0% |
| Pneumonia |
3.0% |
|
